Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

A Word to the Unwise

After a spate of industrial disasters, the public seeks greater oversight of corporations—so does FDA.
Jul 2, 2010

After a spate of industrial disasters, the public seeks greater oversight of corporations—so does FDA.

Anniversary Season

The birth of "the pill" and harmonization created a new paradigm for global standards.
Jun 2, 2010

The birth of "the pill" and harmonization created a new paradigm for global standards.

A Very Brady FDA

FDA wants industry to talk to them about the science underlying process innovations—really.
May 2, 2010

FDA wants industry to talk to them about the science underlying process innovations—really.

Skinny or Dead

If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.
Mar 2, 2010

If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.

Trends in Bioprocessing

The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.This article contains online-exclusive bonus material.
Mar 1, 2010

The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.

Surface Plasmon Resonance as an Analytical Tool for Bioprocessing

A Q&A with GE Healthcare
Mar 1, 2010

A Q&A with GE Healthcare

Science and Sensibility

The death of a pioneer in molecular genetics recalls age-old
questions about social fitness to ensure the ethical uses of scientific advances.

Feb 2, 2010

The death of a pioneer in molecular genetics recalls age-old questions about social fitness to ensure the ethical uses of scientific advances.

Refocusing Our Resources

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.
Jan 2, 2010

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.

Headed Up or Down? Pharma's Position in the Current Economy

Results from our annual employment survey.
Dec 2, 2009

Results from our annual employment survey.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here